Sensus Healthcare (SRTS) insider boosts holdings to 140,113 shares

Rhea-AI Filing Summary

Sensus Healthcare, Inc. director reports open-market stock purchase. A company director filed a Form 4 disclosing the purchase of 7,000 shares of Sensus Healthcare common stock on 11/21/2025 at a price of $3.93 per share. Following this transaction, the director now beneficially owns 140,113 shares, held directly. The filing was made by a single reporting person in their capacity as a director of Sensus Healthcare.

Insider Trade Summary

Net Buyer: 7,000 shares

Net Buy 1 txn

Insider Sachetta Eric

Role Director

Bought 7,000 shs ($28K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	7,000	$3.93	$28K

Holdings After Transaction: Common Stock — 140,113 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 11/21/2025 - 02:28 PM Learn about SEC filing dates

FAQ

What insider transaction was reported for Sensus Healthcare (SRTS)?

A director of Sensus Healthcare, Inc. reported buying 7,000 shares of common stock in an open-market transaction on 11/21/2025 at $3.93 per share.

How many Sensus Healthcare (SRTS) shares does the director own after this trade?

After the reported transaction, the director beneficially owns 140,113 shares of Sensus Healthcare common stock, held directly.

What type of SEC form was filed for the SRTS insider transaction?

The transaction was disclosed on a Form 4, which reports changes in the beneficial ownership of a company's securities by its directors, officers, and large shareholders.

What was the price paid per share in the latest Sensus Healthcare insider purchase?

The director bought the 7,000 shares of Sensus Healthcare common stock at a price of $3.93 per share.

What is the reporting person’s relationship to Sensus Healthcare (SRTS)?

The reporting person in this filing is a director of Sensus Healthcare, Inc. and filed individually as one reporting person.

Were any derivative securities reported for this SRTS insider filing?

The Form 4 includes a section for derivative securities, but in this report there are no derivative transactions listed; only common stock is reported.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sachetta Eric

(Last) (First) (Middle)

10 COBBLESTONE LANE

(Street)

ANDOVER MA 01810

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sensus Healthcare, Inc. [ SRTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/21/2025		P		7,000	A	$3.93	140,113	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Eric Sachetta	11/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.